The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Angiolo Gadducci

Department of Procreative Medicine

University of Pisa

Italy

[email]@*.med.unipi.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Procreative Medicine, University of Pisa, Italy. 2009 - 2010
  • Division of Gynecology and Obstetrics, Department of Procreative Medicine, University of Pisa, Via Roma 56, Italy. 2000 - 2010

References

  1. The perioperative management of patients with gynaecological cancer undergoing major surgery: A debated clinical challenge. Gadducci, A., Cosio, S., Spirito, N., Genazzani, A.R. Crit. Rev. Oncol. Hematol. (2010) [Pubmed]
  2. The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study. Gadducci, A., Cosio, S., Zola, P., Sostegni, B., Ferrero, A.M., Teti, G., Cristofani, R., Sartori, E. Gynecol. Oncol. (2010) [Pubmed]
  3. Pattern of failures and clinical outcome of patients with locally advanced cervical cancer treated with a tailored integrated therapeutic approach. Gadducci, A., Fabrini, M.G., Perrone, F., Manfredi, B., Fanucchi, A., Laliscia, C., Barsotti, C., Scotti, V., Genazzani, A.R., Greco, C. Anticancer Res. (2010) [Pubmed]
  4. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study. Gadducci, A., Cosio, S., Zola, P., Tisi, G., Ferrero, A., Piovano, E., Cristofani, R., Greco, C., Sartori, E. Int. J. Gynecol. Cancer (2010) [Pubmed]
  5. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy. Gadducci, A., Teti, G., Barsotti, C., Tana, R., Fanucchi, A., Orlandini, C., Fabrini, M.G., Genazzani, A.R. Anticancer Res. (2010) [Pubmed]
  6. Weekly low-dose paclitaxel as maintenance treatment in patients with advanced ovarian cancer who had microscopic residual disease at second-look surgery after 6 cycles of paclitaxel/platinum-based chemotherapy: results of an open noncomparative phase 2 multicenter Italian study (After-6 Protocol 2). Gadducci, A., Katsaros, D., Zola, P., Scambia, G., Ballardini, M., Pasquini, E., Fertonani, C., Maggi, L., Pecorelli, S., Conte, P.F. Int. J. Gynecol. Cancer (2009) [Pubmed]
  7. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Gadducci, A., Cosio, S., Tana, R., Genazzani, A.R. Crit. Rev. Oncol. Hematol. (2009) [Pubmed]
  8. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue. Gadducci, A., Biglia, N., Cosio, S., Sismondi, P., Genazzani, A.R. Gynecol. Endocrinol. (2009) [Pubmed]
  9. The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option. Gadducci, A., Spirito, N., Baroni, E., Tana, R., Genazzani, A.R. Gynecol. Endocrinol. (2009) [Pubmed]
  10. Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study. Gadducci, A., Fuso, L., Cosio, S., Landoni, F., Maggino, T., Perotto, S., Sartori, E., Testa, A., Galletto, L., Zola, P. Int. J. Gynecol. Cancer (2009) [Pubmed]
  11. Surveillance of patients after initial treatment of ovarian cancer. Gadducci, A., Cosio, S. Crit. Rev. Oncol. Hematol. (2009) [Pubmed]
  12. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer. Gadducci, A., Cavazzana, A., Cosio, S., DI Cristofano, C., Tana, R., Fanucchi, A., Teti, G., Cristofani, R., Genazzani, A.R. Anticancer Res. (2009) [Pubmed]
  13. Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer. Gadducci, A., Tana, R., Teti, G., Zanca, G., Fanucchi, A., Genazzani, A.R. Int. J. Gynecol. Cancer (2008) [Pubmed]
  14. The management of patients with uterine sarcoma: a debated clinical challenge. Gadducci, A., Cosio, S., Romanini, A., Genazzani, A.R. Crit. Rev. Oncol. Hematol. (2008) [Pubmed]
  15. Molecular target therapies in endometrial cancer: from the basic research to the clinic. Gadducci, A., Tana, R., Cosio, S., Fanucchi, A., Genazzani, A.R. Gynecol. Endocrinol. (2008) [Pubmed]
  16. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature. Gadducci, A., Tana, R., Cosio, S., Genazzani, A.R. Crit. Rev. Oncol. Hematol. (2008) [Pubmed]
  17. Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature. Gadducci, A., Conte, P.F. Int. J. Gynecol. Cancer (2008) [Pubmed]
  18. Ovarian function and childbearing issues in breast cancer survivors. Gadducci, A., Cosio, S., Genazzani, A.R. Gynecol. Endocrinol. (2007) [Pubmed]
  19. Biochemical prognostic factors and risk of relapses in patients with cervical cancer. Gadducci, A., Tana, R., Fanucchi, A., Genazzani, A.R. Gynecol. Oncol. (2007) [Pubmed]
  20. Brain recurrences in patients with ovarian cancer: report of 12 cases and review of the literature. Gadducci, A., Tana, R., Teti, G., Fanucchi, A., Pasqualetti, F., Cionini, L., Genazzani, A.R. Anticancer Res. (2007) [Pubmed]
  21. Intratumoral microvessel density in advanced epithelial ovarian cancer and its use as a prognostic variable. Gadducci, A., Ferrero, A., Cosio, S., Zola, P., Viacava, P., Dompé, D., Fanelli, G., Ravarino, N., Motta, M., Cristofani, R., Genazzani, A.R. Anticancer Res. (2006) [Pubmed]
  22. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies. Gadducci, A., Cosio, S., Genazzani, A.R. Crit. Rev. Oncol. Hematol. (2006) [Pubmed]
  23. P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome. Gadducci, A., Di Cristofano, C., Zavaglia, M., Giusti, L., Menicagli, M., Cosio, S., Naccarato, A.G., Genazzani, A.R., Bevilacqua, G., Cavazzana, A.O. Anticancer Res. (2006) [Pubmed]
  24. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Gadducci, A., Cionini, L., Romanini, A., Fanucchi, A., Genazzani, A.R. Crit. Rev. Oncol. Hematol. (2006) [Pubmed]
  25. Evolving role of serum biomarkers in the management of ovarian cancer. Gadducci, A., Cosio, S., Zanca, G., Genazzani, A.R. Women's. Health. (london,. England) (2006) [Pubmed]
  26. Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study. Gadducci, A., Sartori, E., Landoni, F., Zola, P., Maggino, T., Maggioni, A., Cosio, S., Frassi, E., LaPresa, M.T., Fuso, L., Cristofani, R. J. Clin. Oncol. (2005) [Pubmed]
  27. Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature. Gadducci, A., Cosio, S., Conte, P.F., Genazzani, A.R. Crit. Rev. Oncol. Hematol. (2005) [Pubmed]
  28. Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: results of a multicenter retrospective Italian study. Gadducci, A., Sartori, E., Landoni, F., Zola, P., Maggino, T., Colombo, N., Fanucchi, A., Chiudinelli, F., Lapresa, M., Maria Ferrero, A. Gynecol. Oncol. (2005) [Pubmed]
  29. Polycystic ovary syndrome and gynecological cancers: is there a link?. Gadducci, A., Gargini, A., Palla, E., Fanucchi, A., Genazzani, A.R. Gynecol. Endocrinol. (2005) [Pubmed]
  30. Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer. Gadducci, A., Biglia, N., Sismondi, P., Genazzani, A.R. Gynecol. Endocrinol. (2005) [Pubmed]
  31. Neutropenic enterocolitis in an advanced epithelial ovarian cancer patient treated with paclitaxel/platinum-based chemotherapy: a case report and review of the literature. Gadducci, A., Gargini, A., Palla, E., Fanucchi, A., Genazzani, A.R. Anticancer Res. (2005) [Pubmed]
  32. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Gadducci, A., Cosio, S., Carpi, A., Nicolini, A., Genazzani, A.R. Biomed. Pharmacother. (2004) [Pubmed]
  33. The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma. Gadducci, A., Cosio, S., Fanucchi, A., Negri, S., Cristofani, R., Genazzani, A.R. Gynecol. Oncol. (2004) [Pubmed]
  34. Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body. Gadducci, A., Cosio, S., Genazzani, A.R. Curr. Opin. Investig. Drugs (2004) [Pubmed]
  35. Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma. Gadducci, A., Viacava, P., Cosio, S., Fanelli, G., Fanucchi, A., Cecchetti, D., Cristofani, R., Genazzani, A.R. Anticancer Res. (2003) [Pubmed]
  36. The management of malignant nondysgerminomatous ovarian germ cell tumors. Gadducci, A., Cosio, S., Muraca, S., Genazzani, A.R. Anticancer Res. (2003) [Pubmed]
  37. Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma. Gadducci, A., Viacava, P., Cosio, S., Cecchetti, D., Fanelli, G., Fanucchi, A., Teti, G., Genazzani, A.R. Anticancer Res. (2003) [Pubmed]
  38. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Gadducci, A., Cosio, S., Fanucchi, A., Nardini, V., Roncella, M., Conte, P.F., Genazzani, A.R. Anticancer Res. (2003) [Pubmed]
  39. Current management of fallopian tube carcinoma. Gadducci, A. Curr. Opin. Obstet. Gynecol. (2002) [Pubmed]
  40. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gadducci, A., Landoni, F., Sartori, E., Maggino, T., Zola, P., Gabriele, A., Rossi, R., Cosio, S., Fanucchi, A., Tisi, G. Gynecol. Oncol. (2001) [Pubmed]
  41. The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer. Gadducci, A., Ferdeghini, M., Cosio, S., Fanucchi, A., Cristofani, R., Genazzani, A.R. Int. J. Gynecol. Cancer (2001) [Pubmed]
  42. Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management. Gadducci, A., Cosio, S., Fanucchi, A., Genazzani, A.R. Anticancer Res. (2001) [Pubmed]
  43. Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of advanced cervical cancer. Gadducci, A., Cosio, S., Cionini, L., Genazzani, A.R. Anticancer Res. (2001) [Pubmed]
  44. Treatment options in patients with recurrent ovarian cancer. Gadducci, A., Conte, P., Cianci, C., Negri, S., Genazzani, A.R. Anticancer Res. (2001) [Pubmed]
  45. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Gadducci, A., Iacconi, P., Fanucchi, A., Cosio, S., Teti, G., Genazzani, A.R. Anticancer Res. (2000) [Pubmed]
  46. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci, A., Cosio, S., Fanucchi, A., Cristofani, R., Genazzani, A.R. Anticancer Res. (2000) [Pubmed]
  47. p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen. Gadducci, A., Cianci, C., Cosio, S., Carnino, F., Fanucchi, A., Buttitta, F., Conte, P.F., Genazzani, A.R. Anticancer Res. (2000) [Pubmed]
 
WikiGenes - Universities